Table 2 Retained clinical conditions and QOF indicators (care bundles and components)

Secondary prevention of Coronary Heart Disease (CHD)

The percentage of patients with coronary heart disease:

CHD6

…in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less

CHD8

…whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less

CHD9

…with a record in the previous 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)

CHD10

…who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded)

CHD11

…a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor or Angiotensin II antagonist

CHD12

…who have a record of influenza immunisation in the preceding 1 September to 31 March

Chronic kidney disease (CKD)

The percentage of patients on the CKD register:

CKD3

…whom the last blood pressure reading, measured in the previous 15 months, is 140/85 or less

CKD5

…with hypertension and proteinuria who are treated with an angiotensin converting enzyme inhibitor (ACE – I) or angiotensin receptor blocker (ARB) (unless a contraindication or side effects are recorded)

CKD6

…whose notes have a record of a urine albumin: creatinine ratio (or protein: creatinine ratio) test in the previous 15 months

Diabetes mellitus (DM)

The percentage of patients with diabetes:

DM2

…whose notes record BMI in the previous 15 months

DM24

…in whom the last HbA1c is 8 or less (or equivalent test/reference range depending on local laboratory) in the previous 15 months

DM9

…with a record of the presence or absence of peripheral pulses in the previous 15 months

DM10

…with a record of neuropathy testing in the previous 15 months

DM12

…in whom the last blood pressure is 145/85 or less

DM15

…with a diagnosis of proteinuria or micro-albuminuria who are treated with ACE inhibitors (or A2 antagonists)

DM17

…whose last measured total cholesterol within the previous 15 months is 5 mmol/l or less

DM18

…who have had influenza immunisation in the preceding 1 September to 31 March

Chronic obstructive pulmonary disease (COPD)

The percentage of patients with COPD:

COPD10

…with a record of FeV1 in the previous 15 months

COPD13

…who have had a review, undertaken by a healthcare professional, including an assessment of breathlessness using the MRC dyspnoea score in the preceding 15 months

COPD8

…who have had influenza immunisation in the preceding 1 September to 31 March

Stroke and transient ischaemic attack (Stroke/TIA)

The percentage of patients with:

STROKE6

…a history of TIA or stroke in whom the last blood pressure reading (measured in the previous 15 months) is 150/90 or less

STROKE8

…TIA or stroke whose last measured total cholesterol (measured in the previous 15 months) is 5 mmol/l or less

STROKE12

… with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), m or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)

STROKE10

…TIA or stroke who have had influenza immunisation in the preceding 1 September to 31 March